Sign in

CIK 0001622229 · Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465308248
Phone
617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
  1. 8-K Event Material agreement · New debt or obligation
  2. SCHEDULE 13D/A Stake Beneficial Ownership Report
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 8-K Event Material agreement · Other events
  9. 424B5 Offering Prospectus
  10. 424B5 Offering Prospectus
  11. FWP Offering Free Writing Prospectus
  12. 424B5 Offering Prospectus
  13. 424B5 Offering Prospectus
  14. 8-K Event Regulation FD disclosure · Other events
  15. S-3ASR Offering Registration Statement
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 4 Derivatives Options or other derivatives
  19. 8-K Event Material agreement · New debt or obligation
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 4 of 31 · 616 filings